0649SP |
Methotrexate, Serum/Plasma |
1415B |
Cyclosporine, Blood |
2066B |
Everolimus, Blood |
2531B |
Leflunomide as Metabolite (Therapeutic Drug Monitoring), Blood |
2531SP |
Leflunomide as Metabolite (Therapeutic Drug Monitoring), Serum/Plasma |
2532B |
Leflunomide as Metabolite (Pre-Pregnancy Monitoring), Blood |
2532SP |
Leflunomide as Metabolite (Pre-Pregnancy Monitoring), Serum/Plasma |
3063B |
Mycophenolic Acid and Metabolite, Blood |
3063SP |
Mycophenolic Acid and Metabolite, Serum/Plasma |
3063U |
Mycophenolic Acid and Metabolite, Urine |
3426B |
Perfluorooctanoic Acid, Blood Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3427SP |
Perfluoroalkyl Substances (PFAS), Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3428SP |
PFASure TM, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3429SP |
PFASure TM Expanded, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
4193B |
Sirolimus, Blood |
4306B |
Tacrolimus, Blood |
4366B |
Teriflunomide (Therapeutic Drug Monitoring), Blood |
4366SP |
Teriflunomide (Therapeutic Drug Monitoring), Serum/Plasma |
4367B |
Teriflunomide (Pre-Pregnancy Monitoring), Blood |
4367SP |
Teriflunomide (Pre-Pregnancy Monitoring), Serum/Plasma |
4783B |
Voclosporin, Blood |